EU-LIFE

Building and promoting Excellence in Life Sciences in Europe
Building and promoting Excellence in Life Sciences in Europe

News

EU-LIFE supports open access to scholarly publications recognising the rights of every researcher and citizen to access scientific literature (publishing as well as reading and re-using) as we believe science to be a public good for society.
We appreciate that the Plan S guidance document addresses several concerns raised by our previous statement and by other research communities. However, in answer to the two main questions regarding implementation raised during the public consultation, we believe that cOAlition S should work with diverse stakeholders to address 7 main points.

The Board of Directors of the CTLS (Core Technologies for Life Sciences) association supports the EU-LIFE statement on the small- and medium-sized research infrastructure. CTLS presently brings together 175 members from 18 countries from Europe and beyond.

EU-LIFE Community members held their annual meeting in Barcelona on 23th and 24th of October. This annual event brings the opportunity to strengthen the on-going EU-LIFE collaborations looking for an optimal environment for excellent research. Open science, scientific collaborations, research infrastructure, technology transfer, funding, career development in research were at the heart of the EU-LIFE working groups discussions.

EU-LIFE supports OA to scholarly publications recognizing the rights to every scientist and citizen to access scientific literature (publishing as well as reading and re-using) as we believe science to be a public good for society.
OA implementation requires innovation and a well-thought plan engaging all different actors worldwide. Importantly, OA implementation must ensure high-level quality and fairness of the scientific publication system.
EU-LIFE puts forward 10 key recommendations on the implementation of Plan S.

On July 25th, the Court of Justice of the European Union (ECJ) ruled that organisms obtained by modern forms of mutagenesis such as CRISPR are not exempt from the EU GMO legislation. Consequently, genome edited organisms must comply with the strict conditions of the EU GMO legislation. This is in stark contrast with the opinion of the Advocate-General of the Court, which was published in January of this year and advised ruling otherwise.

 

EU-LIFE call for action on the small- and medium-sized research infrastructures

EU-LIFE urges the European Parliament and the EU Council to push for a strong Horizon Europe

EU-LIFE urges the European Commission (EC), the European Parliament (EP) and the European Council to create a strong Horizon Europe (Framework Programme 9)

2017 Highlights on the three priority areas of EU-LIFE

European policy, open science, scientific collaborations, crisis communication, research infrastructure, technology transfer, talent exchange and career development, funding, data management…